By Abigail Townsend
Date: Monday 01 Nov 2021
(Sharecast News) - British drugs group GlaxoSmithKline has denied speculation it is interested in acquiring Canada's Aurinia Pharmaceuticals.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 15.30 |
| Change Today | $ -0.05 |
| % Change | -0.33 % |
| 52 Week High | $16.37 |
| 52 Week Low | $7.04 |
| Volume | 1,713,537 |
| Shares Issued | 85.32m |
| Market Cap | $1,305.44m |
| RiskGrade | 367 |
| Time | Volume / Share Price |
| 15:59 | 300 @ $15.30 |
| 15:59 | 190 @ $15.30 |
| 15:59 | 188 @ $15.30 |
| 15:59 | 120 @ $15.30 |
| 15:59 | 240 @ $15.30 |
You are here: research